Affordable Access

Access to the full text

Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma

  • Xie, Ji-yan1, 1
  • Wei, Jin-xing1
  • Lv, Li-hong1
  • Han, Qing-fang2
  • Yang, Wei-bang1
  • Li, Guo-lin1
  • Wang, Pan-xia3
  • Wu, Shao-bin1
  • Duan, Jin-xin1
  • Zhuo, Wen-feng1
  • Liu, Pei-qing3
  • Min, Jun1
  • 1 Sun Yat-sen University, Guangzhou, 510120, China , Guangzhou (China)
  • 2 The First Affiliated Hospital of Zhengzhou University, No.1, Jianshedong Road, Zhengzhou, Henan Province, 450052, China , Zhengzhou (China)
  • 3 Sun Yat-sen University, Guangzhou, 510006, China , Guangzhou (China)
Published Article
Cell Communication and Signaling
BioMed Central
Publication Date
Mar 17, 2020
DOI: 10.1186/s12964-020-00535-8
Springer Nature


BackgroundHepatocellular carcinoma (HCC) is the most common primary liver cancer and is a highly vascularized solid tumor. Angiopoietin-2 (ANGPT2) has been described as an attractive target for antiangiogenic therapy. Exosomes are small extracellular vesicles secreted by most cell types and contribute to cell-to-cell communication by delivering functional cargo to recipient cells. The expression of ANGPT2 in tumor-derived exosomes remains unknown.MethodsWe detected the ANGPT2 expression in HCC-derived exosomes by immunoblotting, enzyme-linked immunosorbent assay and immunogold labeling, then observed exosomal ANGPT2 internalization and recycling by confocal laser scanning microscopy, co-immunoprecipitation and immunoblotting. We used two HCC cell lines (Hep3B and MHCC97H) to overexpress ANGPT2 by lentivirus infection or knockdown ANGPT2 by the CRISPR/Cas system, then isolated exosomes to coculture with human umbilical vein endothelial cells (HUVECs) and observed the angiogenesis by Matrigel microtubule formation assay, transwell migration assay, wound healing assay, cell counting kit-8 assay, immunoblotting and in vivo tumorigenesis assay.ResultsWe found that HCC-derived exosomes carried ANGPT2 and delivered it into HUVECs by exosome endocytosis, this delivery led to a notable increase in angiogenesis by a Tie2-independent pathway. Concomitantly, we observed that HCC cell-secreted exosomal ANGPT2 was recycled by recipient HUVECs and might be reused. In addition, the CRISPR-Cas systems to knock down ANGPT2 significantly inhibited the angiogenesis induced by HCC cell-secreted exosomal ANGPT2, and obviously suppressed the epithelial-mesenchymal transition activation in HCC.ConclusionsTaken together, these results reveal a novel pathway of tumor angiogenesis induced by HCC cell-secreted exosomal ANGPT2 that is different from the classic ANGPT2/Tie2 pathway. This way may be a potential therapeutic target for antiangiogenic therapy.Video Abstract

Report this publication


Seen <100 times